Dental Anesthesia Market Report 2026

The dental anesthesia market size has grown strongly in recent years. It will grow from $2.19 billion in 2025 to $2.33 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising dental procedure volumes, patient fear of dental pain, reliance on lidocaine-based products, growth of dental clinics, outpatient dental care expansion.

The dental anesthesia market size is expected to see strong growth in the next few years. It will grow to $3.02 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to advancements in anesthetic formulations, growth of cosmetic dentistry, increasing dental awareness, expansion of dental insurance coverage, improved safety profiles. Major trends in the forecast period include growing demand for pain-free dental procedures, increased use of local anesthetics, expansion of outpatient dental surgeries, rising adoption of sedation dentistry, development of long-acting anesthetic agents.

The high prevalence of dental diseases is expected to drive the growth of the dental anesthesia market in the coming years. The prevalence of dental diseases represents the share of individuals in a population affected by a specific dental condition at a given time. Dental anesthesia helps reduce pain and discomfort associated with dental conditions by numbing the treated area, allowing patients to better tolerate procedures that may otherwise be painful or uncomfortable, such as fillings, root canal treatments, or tooth extractions. As the incidence of dental diseases continues to rise, the demand for such procedures increases, leading to greater utilization of dental anesthesia. For instance, in March 2023, according to the World Health Organization, a Switzerland-based international health organization, oral diseases affected approximately 3.5 billion people worldwide, including around 2 billion individuals with caries of permanent teeth and about 514 million children suffering from caries of primary teeth. As a result, the widespread occurrence of dental diseases is contributing to the expansion of the dental anesthesia market.

Major companies operating in the dental anesthesia market are introducing advanced solutions, such as computer-controlled local anesthetic delivery systems, to minimize pain and anxiety during dental injections. A computer-controlled local anesthetic delivery (CCLAD) system is a sophisticated dental device that administers anesthesia slowly and accurately, reducing patient discomfort while improving ease of use for dental professionals, particularly when treating pediatric or anxious patients. For example, in November 2023, Convergent Dental Inc., a US-based dental equipment and technology company, launched Solea Protect. This innovative application of the Solea All-Tissue Dental Laser is designed to prevent tooth decay by reducing mineral loss in dental enamel. The treatment uses advanced CO2 laser technology with a unique 9.3-micron wavelength to gently heat the enamel surface, removing impurities that weaken tooth structure. This process creates a stronger, crystal-like enamel that is more resistant to decay. When combined with fluoride, Solea Protect significantly enhances protective effects, reducing mineral loss beyond what fluoride alone can achieve. Clinical studies demonstrated that patients treated with Solea Protect and fluoride required no caries restorations within one year, highlighting its effectiveness in caries prevention and offering a convenient, anxiety-free solution for both dentists and patients.

In August 2023, Pierrel S.p.A., an Italy-based pharmaceutical manufacturing company, acquired the dental local anesthetic portfolio of 3M Company for an undisclosed amount. Through this acquisition, Pierrel obtained access to 3M’s well-established dental anesthetic brands and associated assets, enabling the company to broaden its product portfolio while strengthening its global commercial presence and manufacturing capabilities in the dental anesthesia segment. 3M Company is a US-based diversified technology and manufacturing organization with a strong footprint in healthcare and oral care solutions, recognized for its long-standing expertise in producing high-quality dental anesthetic products.

Major companies operating in the dental anesthesia market are Dentsply Sirona, B. Braun Melsungen AG, Acteon Group, Sedana Medical AB, DentalEZ Group, 3M Company, Coltene Holding AG, Milestone Scientific, Septodont, Laboratorios Inibsa, Pierrel S.p.A., Normon Laboratories, Aseptico, Ultradent Products Inc., Sunstar Americas, Huons Global, Primex Pharmaceuticals, Aspen Pharmacare, Zeyco, Dentalhitec.

North America was the largest region in the dental anesthesia market in 2025. The regions covered in the dental anesthesia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dental anesthesia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the dental anesthesia market by increasing costs of imported anesthetic drugs, syringes, and delivery devices. Dental clinics and hospitals in North America and Europe are most affected due to reliance on imported anesthetic products, while Asia-Pacific faces higher procedural costs. These tariffs are increasing treatment expenses. However, they are also supporting local pharmaceutical manufacturing and dental supply production.

The dental anesthesia market research report is one of a series of new reports that provides dental anesthesia market statistics, including dental anesthesia industry global market size, regional shares, competitors with a dental anesthesia market share, detailed dental anesthesia market segments, market trends and opportunities, and any further data you may need to thrive in the dental anesthesia industry. This dental anesthesia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dental anesthesia is a form of anesthesia used to numb the teeth, gums, and surrounding tissues of the mouth and jaw during dental procedures. It is applied to desensitize oral tissues and prevent pain in a specific area of the mouth during treatment by blocking the nerves responsible for sensing or transmitting pain.

The main types of dental anesthesia include local anesthesia, general anesthesia, and sedation. Local anesthesia is a type of anesthesia that numbs a targeted area of the body. In dentistry, local anesthesia is used to numb specific regions of the mouth, such as the gums, teeth, or tongue, during dental treatments. Common product types include lidocaine, mepivacaine, prilocaine, articaine, and others, which are administered through oral, intravenous, and other routes, and are available in short-, medium-, and long-duration formulations. The primary end users of dental anesthesia include hospitals, dental clinics, and others.

The dental anesthesia market consists of sales of bupivacaine and propofol. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.